Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody targeting human ICAM-1, reduces leukocyte adhesion to the vascular endothelium, thus diminishing leukocyte extravasation and inflammatory tissue damage. This compound exhibits anti-inflammatory properties and is utilized in stroke research [1] [2].
説明 | Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody targeting human ICAM-1, reduces leukocyte adhesion to the vascular endothelium, thus diminishing leukocyte extravasation and inflammatory tissue damage. This compound exhibits anti-inflammatory properties and is utilized in stroke research [1] [2]. |
分子量 | N/A |
CAS No. | 142864-19-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Enlimomab 142864-19-5 Inhibitor inhibitor inhibit